Updated
31/07/2025
10:15
HRTS US
Updated 31/07/2025 10:15
MM is neutral towards HRTS
Tema Heart & Health ETF (HRTS US)
HRTS US$38.55
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 38.55
- Change
- ▲ 0.08 (0.20)
- Bid / Ask
- 38.45 - 38.54
- Volume
- 541
- Turnover
- 15,423
- Open
- 38.59
- Day Range
- 37.96 - 38.59
- VWAP
- 38.56
- Prev Close
- 38.47
- Last Trade
- 09/11 3:00pm
Fund profile
Displays who issues the fund, how it is structured and invests, its Morningstar category and benchmark, size, headline costs and dates, sourced from Morningstar. Fund size counts every class of the fund; ETF net assets is this listing alone.
Fund size
$57.0M
NOV 2026
Distributions
Monthly
Since inception
3.0 yrs
NOV 2023
- Legal name
- Tema Heart & Health ETF
- Issuer
- Tema ETFs
- Type
- Exchange-Traded Fund
- Structure
- Open Ended Investment Company
- Management style
- Actively managed
- Morningstar category
- Health
- Category index
- Morningstar US Health TR USD
- Benchmark
- S&P 500 (TR) (1970)
- ETF net assets
- $57.0M
- Units on issue
- 1.5M
- Management fee
- 0.99% p.a.
- Domicile
- United States
- Base currency
- USD
- Inception
- 20 NOV 2023
- Listed
- 21 NOV 2023
- Index provider
- Standard and Poors
Objective and strategy
The investment seeks to provide long-term growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Asset allocation
Displays how the fund is split between shares, bonds, cash and other assets, sourced from Morningstar.
US equity 80.07%Non-US equity 19.64%
| Asset class | Net % | Long % | Short % |
|---|---|---|---|
| Equity | 99.70 | 99.70 | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Cash | 0.30 | 0.59 | 0.29 |
| Other | 0.00 | 0.00 | 0.00 |
Sector exposure
Displays the share of the fund held in each sector, sourced from Morningstar.
Cyclical 0.00%Sensitive 0.00%Defensive 100.00%
- Healthcare
- 100.00%
- Basic Materials
- 0.00%
- Consumer Cyclical
- 0.00%
- Financial Services
- 0.00%
- Real Estate
- 0.00%
- Communication Services
- 0.00%
- Energy
- 0.00%
- Industrials
- 0.00%
- Technology
- 0.00%
- Consumer Defensive
- 0.00%
- Utilities
- 0.00%
Region exposure
Displays the share of the fund held in each region, sourced from Morningstar.
Developed markets 100.00%Emerging markets 0.00%
- North America
- 80.85%
- Europe Developed
- 12.02%
- United Kingdom
- 3.29%
- Japan
- 2.63%
- Africa / Middle East
- 1.21%
- Latin America
- 0.00%
- Europe Emerging
- 0.00%
- Australasia
- 0.00%
- Asia Developed
- 0.00%
- Asia Emerging
- 0.00%
Country exposure
Displays the twelve countries the fund holds most of, sourced from Morningstar.
- United States
- 80.30%
- Switzerland
- 8.03%
- Denmark
- 3.99%
- United Kingdom
- 3.29%
- Japan
- 2.63%
- Israel
- 1.21%
- Canada
- 0.55%
Style box
Displays where the fund's shareholdings sit on Morningstar's style box: size (large, mid, small) down and investment style (value, blend, growth) across, sourced from Morningstar.
LargeMidSmallValueBlendGrowth
- Style
- Large Blend
- Average moat
- Wide
Size score
234
Small
Mid
Large
Value-growth score
133
Value
Blend
Growth
Economic moat
Wide 63%Narrow 28%None 10%
Market capitalisation
Displays the share of the fund's shareholdings in giant, large, mid, small and micro cap companies, sourced from Morningstar.
- Giant
- 27.47%
- Large
- 47.21%
- Mid
- 10.90%
- Small
- 12.89%
- Micro
- 1.53%
Giant 27%Large 47%Mid 11%Small 13%Micro 2%
- Average market cap
- $133.99B
- Number of holdings
- 47
- Shares held
- 46
Portfolio statistics · 5 NOV 2026
Displays the valuation, yield, size, concentration and quality of the fund's shareholdings taken together (trailing twelve months), sourced from Morningstar.
- Price / earnings
- 29.61
- Price / book
- 5.83
- Price / sales
- 2.41
- Price / cash flow
- 18.53
- Dividend yield
- 1.12%
- Assets in top 10
- 46.74%
- Return on equity
- 24.52%
- Net margin
- 14.98%
- Earnings growth (3 yr)
- 19.08%
Top holdings · top 10 = 47.65% of assets
Displays the fund's ten largest holdings and their weight in the portfolio, sourced from Morningstar.
| Holding | % Weight | First bought | Market value | Currency | Units held | Sector | Country | |
|---|---|---|---|---|---|---|---|---|
| Eli Lilly and Co LLY | 12.79 | FEB 2026 | 7.4M | USD | 5,191 | Healthcare | United States | |
| Thermo Fisher Scientific Inc TMO | 5.31 | FEB 2026 | 3.1M | USD | 4,382 | Healthcare | United States | |
| Merck & Co Inc MRK | 4.49 | FEB 2026 | 2.6M | USD | 17,262 | Healthcare | United States | |
| Roche Holding AG ADR RHHBY | 4.39 | FEB 2026 | 2.5M | USD | 41,224 | Healthcare | Switzerland | |
| Kodiak Sciences Inc KOD | 3.73 | AUG 2026 | 2.1M | USD | 21,612 | Healthcare | United States | |
| BridgeBio Pharma Inc BBIO | 3.55 | FEB 2026 | 2.0M | USD | 27,247 | Healthcare | United States | |
| Revolution Medicines Inc Ordinary Shares RVMD | 3.55 | FEB 2026 | 2.0M | USD | 10,664 | Healthcare | United States | |
| UnitedHealth Group Inc UNH | 3.35 | FEB 2026 | 1.9M | USD | 4,734 | Healthcare | United States | |
| Johnson & Johnson JNJ | 3.28 | FEB 2026 | 1.9M | USD | 6,907 | Healthcare | United States | |
| AstraZeneca PLC AZN | 3.22 | FEB 2026 | 1.9M | GBP | 9,903 | Healthcare | United Kingdom |
Trailing returns · 31 OCT 2026
Displays total returns after fees at net asset value, the return at the ASX market price, the return before fees, and where the fund ranks among funds in its Morningstar category, sourced from Morningstar.
Fund (NAV) Market price
1M
7.2
3M
6.8
6M
15.6
YTD
10.1
1Y
21.1
| Period | Fund (NAV) % | Market price % | Before fees % | Rank in category |
|---|---|---|---|---|
| 1 month | 7.21 | 7.04 | 7.28 | 62 / 176 |
| 3 months | 6.82 | 6.69 | 7.02 | 72 / 175 |
| 6 months | 15.57 | 15.50 | 16.00 | 86 / 171 |
| Year to date | 10.12 | 10.16 | 10.81 | 89 / 171 |
| 1 year | 21.06 | 20.96 | 21.97 | 72 / 170 |
Returns to 31 OCT 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.
Calendar year returns
Displays the total return after fees and the capital (price) return for each calendar year, with the fund's rank in its Morningstar category, sourced from Morningstar.
Total Capital
2024
-3.6
2025
23.6
| Year | Total % | Capital % | Rank in category |
|---|---|---|---|
| 2025 | 23.64 | 22.00 | 37 / 172 |
| 2024 | -3.60 | -4.07 | 85 / 176 |
Risk statistics · 31 OCT 2026
Displays how the fund has moved relative to its category index: alpha (return beyond the index), beta (sensitivity to it), R-squared (how much the index explains), volatility and risk-adjusted returns, sourced from Morningstar.
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Alpha | 14.72 | — | — | — |
| Beta | 0.21 | — | — | — |
| R-squared | 3.82 | — | — | — |
| Standard deviation | 15.67 | — | — | — |
| Sharpe ratio | 1.06 | — | — | — |
| Sortino ratio | 2.05 | — | — | — |
| Tracking error | 19.15 | — | — | — |
| Information ratio | 0.47 | — | — | — |
| Upside capture % | 74.88 | — | — | — |
| Downside capture % | -19.41 | — | — | — |
| Maximum drawdown % | -7.05 | — | — | — |
Measured against Morningstar Global TME NR USD with USTREAS T-Bill Auction Ave 3 Mon as the risk-free rate, to 31 OCT 2026. Maximum drawdown is on gross returns at the latest quarter end.
Portfolio risk score
Displays Morningstar's Portfolio Risk Score for the fund's holdings, how closely the ETF tracks its index day to day, the estimated cost of holding it against the index, the cost of trading it at market size, and its best and worst quarters since inception, sourced from Morningstar.
Risk score
65.4
Cash 0
Global shares 100
Morningstar Portfolio Risk Score at 30 SEP 2026.
- Market impact cost %
- 0.075
Fees and costs
Displays the fund's ongoing costs as a percentage of assets per year: the PDS management fees and costs, performance fee and transaction costs that make up the total cost ratio (the RG 97 forward estimate, and what was charged last financial year), and the buy / sell spread, sourced from Morningstar.
- Management fees and costs
- 0.99% p.a.
- PDS dated
- 29 JUN 2026
Distributions
Displays the most recent distribution paid per unit and its key dates, sourced from Morningstar.
- Latest distribution
- 0.4729
- Ex Date
- 10 DEC 2025
- Record Date
- 10 DEC 2025
- Pay Date
- 11 DEC 2025
- NAV at ex date
- 34.64
Distributions by year
Displays the total distributions paid per unit in each calendar year, sourced from Morningstar.
2024
0.5
2023
0.1
| Year | Per unit ($) |
|---|---|
| 2024 | 0.4729 |
| 2023 | 0.1429 |
Distribution history
Displays the most recent distributions by ex date, sourced from Morningstar.
| Ex Date | Per unit ($) |
|---|---|
| 10 DEC 2025 | 0.4729 |
| 11 DEC 2024 | 0.1429 |
Sustainability rating · 31 AUG 2026
Displays the Morningstar Sustainability Rating (1 to 5 globes, more is better) and the portfolio ESG risk score behind it (lower is less risk), against the average of the fund's global category, sourced from Morningstar and Sustainalytics.
Average
ESG risk score
20.27
Negligible
Low
Medium
High
Severe
- Rank in category
- 46th percentile
- Environmental risk
- 1.99
- Social risk
- 8.70
- Governance risk
- 3.59
- Portfolio covered
- 99.0%
ESG risk of holdings
Displays the share of the covered portfolio held in companies with negligible, low, medium, high and severe ESG risk, sourced from Morningstar and Sustainalytics.
- Negligible
- 3.04%
- Low
- 54.67%
- Medium
- 28.41%
- High
- 13.89%
- Severe
- 0.00%
9.06% of assets are in companies with high or severe controversies.
Carbon · 31 AUG 2026
Displays the portfolio carbon risk score (lower is less exposure to the transition to a low-carbon economy), the share of the portfolio in companies with fossil fuel revenue, and whether the fund earns Morningstar's Low Carbon Designation, sourced from Morningstar and Sustainalytics.
Carbon risk score
2.30
Low
Medium
High
Severe
Category average 2.74
- Carbon risk
- Low Risk
- Rank in category
- 16th percentile of 313 funds
- Fossil fuel involvement
- 0.00%
- Category average
- 0.16%
- Low Carbon Designation
- Yes
- Portfolio covered
- 98.5%
Fund managers
Displays the people Morningstar lists as managers of the fund, sourced from Morningstar.
- Yuri Khodjamirian
- Andrew (Andy) Hicks
- Qiao Duan
- Maurits Pot
- David Song
Tenure
Displays how long the managers have run the fund: the average and longest tenure, who has served longest, the latest appointment and how many other funds the team manages, sourced from Morningstar.
- Number of managers
- 5
- Average tenure
- 1.1 years
- Longest tenure
- 3.0 years
- Longest serving
- David Song · since 20 NOV 2023
- Most recent appointment
- Yuri Khodjamirian, Maurits Pot · since 29 JUN 2026
- Managed since
- 20 NOV 2023
- Other funds managed
- 164
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
